Clinical trials
Psoriasis clinical trials
A skin condition that causes a rash with itchy, scaly patches. We’re tracking 163 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07017699Recruiting
Deucravacitinib safety during pregnancy study
This study looks at how safe the medicine deucravacitinib (used for psoriasis) is during pregnancy. It compares pregnant women who took deucravacitinib to those who did not, to see if there are any effects on the baby.
La Jolla, CaliforniaAges Any age - NCT07021495Recruiting
Skin disease study to improve treatment choices
This study looks at different skin diseases to find markers that can help guide treatment. It tests new treatments for several conditions like eczema, psoriasis, and lupus, with the goal of personalizing care.
Nijmegen, GelderlandAges 18 years+ - NCT07033234RecruitingPhase 1
Safety study of HS-20118 in healthy volunteers and psoriasis patients
This study tests a new oral medication (HS-20118) for safety and how it works in the body. It is for healthy volunteers or people with chronic plaque psoriasis, and will help see if the drug is safe and how it behaves with or without food.
Hangzhou, ZhejiangAges 18–65 - NCT07086599Recruiting
Sleep problems in psoriatic arthritis and SAPHO syndrome
This study looks at sleep problems in people with psoriatic arthritis or SAPHO syndrome. Participants will stay in the hospital for special sleep tests to understand their sleep issues better.
ParisAges 18 years+ - NCT07086924Recruiting
Gene change and methotrexate response in psoriasis
This study looks at a specific gene change (called TRAF3IP2) in people with psoriasis or psoriatic arthritis who are about to start methotrexate. The goal is to see if the gene affects how well the treatment works or if it causes side effects.
QinaAges 18–70 - NCT07128472Recruiting
Genetic marker study in severe psoriasis with psoriatic arthritis
This study looks at a genetic marker (IL-12B) in people with severe psoriasis and psoriatic arthritis who are already on Humira. It may help understand why some people respond better to treatment.
QinaAges 18–70 - NCT07183423Recruiting
New skin barrier product vs. Vaseline for dry, irritated skin
This study tests a new skin barrier product against a standard moisturizer (petrolatum) to see which works better for mild to moderate skin problems like eczema, psoriasis, or dry skin. It may help improve your skin's barrier and reduce symptoms.
Makati City, National Capital RegionAges 18 years+ - NCT07234838Recruiting
Biologics for psoriasis and risk of genital warts
This study looks at whether biologic medicines for psoriasis affect the risk of developing genital warts. You may join if you have moderate to severe psoriasis and are starting or already on a biologic.
Brussels, Brussels CapitalAges 18 years+ - NCT07250997Recruiting
PALLAS laser study for skin conditions
This trial tests a new laser (PALLAS) that delivers targeted UVB light to treat skin conditions like psoriasis or eczema. It may help if your doctor thinks your skin problem could improve with UVB therapy.
Szeged, Csongrád-Csanád VármegyeAges 18–65 - NCT07258745RecruitingPhase 1
Comparing a risankizumab biosimilar to Skyrizi in healthy adults
This study tests a new biosimilar medicine (CKD-704) to see how it compares to the approved Skyrizi treatments for healthy adults. It checks how the medicine moves through the body, its safety, and how the immune system responds.
Warsaw, WarszawaAges 18–55 - NCT06702293Recruiting
A therapy app to help with itch from skin conditions
This trial tests a mobile app designed to help reduce itching and related symptoms for people with psoriasis, eczema, or chronic hives. If you have moderate to severe itch and can use an English-language app, this study might be for you.
Singapore, SingaporeAges 16 years+ - NCT01706692Recruiting
Study registry for targeted treatments in psoriasis patients
This trial is a registry that collects information from adults with plaque psoriasis or psoriatic arthritis who are starting a new biologic or other systemic treatment. It helps researchers understand how these treatments are used in real life and what outcomes they may have.
AarauAges 18 years+ - NCT02103361Recruiting
Pregnancy registry for Stelara or Tremfya exposure
This study is a pregnancy exposure registry. It collects information to better understand pregnancy outcomes after exposure to Stelara or Tremfya (medicines used for autoimmune diseases).
La Jolla, CaliforniaAges Any age - NCT02719314Recruiting
Study bone loss from steroid use in people with inflammatory disease
This study looks at how steroid medicines (called glucocorticoids) affect bone strength in people with long-term inflammatory rheumatic conditions or psoriasis. It may help improve how doctors check and manage osteoporosis risk and bone metabolism over time.
BerlinAges 18 years+ - NCT03358693Recruiting
Study of inflammation patterns in chronic skin diseases
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
KielAges Any age - NCT07430319Recruiting
Real-life study of guselkumab dosing intervals
This trial is for people with skin psoriasis who are already taking guselkumab (Tremfya) and have their shots spaced 9 weeks or longer apart. Researchers will see how well the skin is controlled with this longer interval.
Nice, Alpes MaritimesAges 18 years+ - NCT07455578RecruitingPhase 1
Study of S-4321 for people with autoimmune or immune diseases
This trial tests a new medicine, S-4321, for people with various autoimmune conditions like rheumatoid arthritis, psoriasis, eczema, or lupus. It aims to see if the drug is safe and can help control the overactive immune system.
Charlestown, New South WalesAges 18–75 - NCT07050810Enrolling by invitationEarly Phase 1
Bath system for chronic skin conditions
This study tests a special bath system (Thera-Clean Microbubbles) to see if it helps people with certain skin conditions like psoriasis, eczema, epidermolysis bullosa, or ichthyosis. It's designed for people whose skin is stable and who can follow a home bathing routine.
Chicago, IllinoisAges 2 years+ - NCT06583395Enrolling by invitation
Meditation retreat study with fitness tracker
This trial studies people attending a 7-day meditation retreat to see how meditation affects well-being. You will wear a fitness tracker and answer surveys.
Palm Desert, CaliforniaAges 21 years+
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for psoriasis?
- Yes. Clin2 currently lists 163 recruiting psoriasis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a psoriasis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a psoriasis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.